🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Antiepileptic Drugs in Elderly Patients

Recruitingn/aAges 65 Years - 100 YearsAllWei Zhao
NCT05459597 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose is to study the population pharmacokinetics, effectiveness and safety of antiepileptic drug (phenytoin, carbamazepine, lamotrigine, levetiracetam, parempanel, etc) in elderly patients and recommend optimized dosage regimens.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age ≥65 years old; 2. Diagnosed with epilepsy; 3. Using antiepileptic drugs for treatment; Exclusion Criteria: 1. Patients who are expected to die within 48 hours; 2. Patients with allergy to antiepileptic drugs; 3. Patients receiving other investigational drugs; 4. Other factors that the researcher considers unsuitable for inclusion.
💊

What it tests

  • antiepileptic drugs
📍

Where

1 site
Wei Zhao
Jinan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy